UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Series B Preferred Stock	Common Stock	Additional Paid in capital	Additional Paid in capital Series B Preferred Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2023			199,133,827
Beginning balances at Dec. 31, 2023	$ (110,800)		$ 21	$ 765,018		$ 7	$ (875,846)
Increase (decrease) in stockholders' equity [Roll Forward]
Stock-based compensation	2,941			2,941
Release of restricted stock units (in shares)			657,605
Cancellation of shares used to settle payroll tax withholding (in shares)			(251,967)
Cancellation of shares used to settle payroll tax withholding	(308)			(308)
Issuance of common stock (in shares)			7,239,982
Issuance of common stock	7,207		$ 1	7,206
Remeasurement of Preferred Stock	0
Foreign currency translation adjustment	(5)					(5)
Net income (loss)	(46,708)						(46,708)
Ending balances (in shares) at Mar. 31, 2024			206,779,447
Ending balances at Mar. 31, 2024	$ (147,673)		$ 22	774,857		2	(922,554)
Beginning balances (in shares) at Dec. 31, 2024	221,791,205		221,791,205
Beginning balances at Dec. 31, 2024	$ (1,070,463)		$ 23	534,726		(43,496)	(1,561,716)
Increase (decrease) in stockholders' equity [Roll Forward]
Stock-based compensation	7,447			7,447
Exercise of warrants (in shares)			4,393,102
Exercise of warrants	25,862			25,862
Exercise of stock options (in shares)			198,398
Exercise of stock options	319			319
Release of restricted stock units (in shares)			749,416
Cancellation of shares used to settle payroll tax withholding (in shares)			(82,438)
Cancellation of shares used to settle payroll tax withholding	(488)			(488)
Remeasurement of Preferred Stock	79,997	$ 79,997			$ 79,997
Foreign currency translation adjustment	7					7
Net income (loss)	$ 15,136						15,136
Ending balances (in shares) at Mar. 31, 2025	227,049,683		227,049,683
Ending balances at Mar. 31, 2025	$ (942,183)		$ 23	$ 647,863		$ (43,489)	$ (1,546,580)